Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-03 Sale | 2026-09-04 9:30 pm | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 19,023 | $37.94 | $721,733 | 1,494,640 (Direct) | View |
| 2026-06-25 Sale | 2026-06-26 4:30 pm | Definium Therapeutics Inc. | DFTX | Sullivan Mark Chief Legal Officer | 13,008 | $45.03 | $585,750 | 320,571 (Direct) | View |
| 2026-06-25 Sale | 2026-06-26 4:30 pm | Definium Therapeutics Inc. | DFTX | Roberts Brandi Chief Financial Officer | 3,013 | $45.03 | $135,675 | 209,487 (Direct) | View |
| 2026-06-25 Sale | 2026-06-26 4:30 pm | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 29,208 | $45.03 | $1,315,236 | 1,098,246 (Direct) | View |
| 2026-06-25 Sale | 2026-06-26 4:30 pm | Definium Therapeutics Inc. | DFTX | Karlin Daniel Chief Medical Officer | 10,035 | $45.03 | $451,876 | 503,282 (Direct) | View |
| 2026-06-25 Sale | 2026-06-26 4:30 pm | Definium Therapeutics Inc. | DFTX | Wiley Matthew T. Chief Commercial Officer | 2,867 | $45.03 | $129,101 | 174,633 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 6:43 pm | Definium Therapeutics Inc. | DFTX | Karlin Daniel Chief Medical Officer | 8,018 | $18.47 | $148,092 | 413,317 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 6:42 pm | Definium Therapeutics Inc. | DFTX | Sullivan Mark Chief Legal Officer | 10,702 | $18.47 | $197,666 | 271,079 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 6:42 pm | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 24,431 | $18.47 | $451,241 | 752,454 (Direct) | View |
| 2025-12-26 Sale | 2025-12-29 5:00 pm | Mind Medicine (MindMed) Inc. | MNMD | Karlin Daniel Chief Medical Officer | 5,600 | $13.15 | $73,623 | 425,025 (Direct) | View |
| 2025-12-26 Sale | 2025-12-29 5:00 pm | Mind Medicine (MindMed) Inc. | MNMD | Barrow Robert Chief Executive Officer | 25,791 | $13.15 | $339,072 | 778,477 (Direct) | View |
| 2025-12-26 Sale | 2025-12-29 5:00 pm | Mind Medicine (MindMed) Inc. | MNMD | Sullivan Mark Chief Legal Officer | 11,276 | $13.15 | $148,244 | 282,576 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-14 Option Award | 2026-09-14 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Karlin Daniel Chief Medical Officer | 200,000 | $0 | 803,699 (Direct) | View |
| 2026-09-14 Option Award | 2026-09-14 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Wiley Matthew T. Chief Commercial Officer | 125,000 | $0 | 362,133 (Direct) | View |
| 2026-09-14 Option Award | 2026-09-14 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Sullivan Mark Chief Legal Officer | 125,000 | $0 | 508,279 (Direct) | View |
| 2026-09-14 Option Award | 2026-09-14 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Roberts Brandi Chief Financial Officer | 125,000 | $0 | 397,905 (Direct) | View |
| 2026-09-14 Option Award | 2026-09-14 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 750,000 | $0 | 2,244,640 (Direct) | View |
| 2026-09-02 Option Award | 2026-09-04 9:30 pm | N/A N/A | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 40,000 | $0 | 1,494,640 (Direct) | View |
| 2026-08-12 Option Award | 2026-08-12 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 375,000 | $0 | 1,473,246 (Direct) | View |
| 2026-08-12 Option Award | 2026-08-12 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Karlin Daniel Chief Medical Officer | 100,000 | $0 | 603,282 (Direct) | View |
| 2026-08-12 Option Award | 2026-08-12 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Sullivan Mark Chief Legal Officer | 62,500 | $0 | 383,071 (Direct) | View |
| 2026-08-12 Option Award | 2026-08-12 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Wiley Matthew T. Chief Commercial Officer | 62,500 | $0 | 237,133 (Direct) | View |
| 2026-08-12 Option Award | 2026-08-12 08:30 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Roberts Brandi Chief Financial Officer | 62,500 | $0 | 271,987 (Direct) | View |
| 2026-06-22 Option Award | 2026-06-22 09:45 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Wiley Matthew T. Chief Commercial Officer | 62,500 | $0 | 177,500 (Direct) | View |
| 2026-06-22 Option Award | 2026-06-22 09:45 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 375,000 | $0 | 1,127,454 (Direct) | View |
| 2026-06-22 Option Award | 2026-06-22 09:45 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Roberts Brandi Chief Financial Officer | 62,500 | $0 | 212,500 (Direct) | View |
| 2026-06-22 Option Award | 2026-06-22 09:45 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Sullivan Mark Chief Legal Officer | 62,500 | $0 | 333,579 (Direct) | View |
| 2026-06-22 Option Award | 2026-06-22 09:45 am | N/A N/A | Definium Therapeutics Inc. | DFTX | Karlin Daniel Chief Medical Officer | 100,000 | $0 | 513,317 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 4:30 pm | N/A 2036-06-10 | Definium Therapeutics Inc. | DFTX | CRYSTAL ROGER Director | 23,854 | $0 | 43,477 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 4:30 pm | N/A 2036-06-10 | Definium Therapeutics Inc. | DFTX | GRYSKA DAVID W Director | 23,854 | $0 | 39,088 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 4:30 pm | N/A 2036-06-10 | Definium Therapeutics Inc. | DFTX | Vallone Carol A Director | 23,854 | $0 | 40,398 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 4:30 pm | N/A 2036-06-10 | Definium Therapeutics Inc. | DFTX | Krebs Andreas Director | 23,854 | $0 | 38,961 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 4:30 pm | N/A 2036-06-10 | Definium Therapeutics Inc. | DFTX | Adsett Roger Director | 18,175 | $0 | 18,175 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 4:30 pm | N/A 2036-06-10 | Definium Therapeutics Inc. | DFTX | Bruhn Suzanne Louise Director | 23,854 | $0 | 43,477 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 5:00 pm | N/A N/A | Definium Therapeutics Inc. | DFTX | Wiley Matthew T. Chief Commercial Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 4:57 pm | N/A N/A | Definium Therapeutics Inc. | DFTX | Roberts Brandi Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 4:55 pm | N/A N/A | Definium Therapeutics Inc. | DFTX | Sullivan Mark Chief Legal Officer | 125,000 | $0 | 407,576 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 4:54 pm | N/A N/A | Definium Therapeutics Inc. | DFTX | Karlin Daniel Chief Medical Officer | 150,000 | $0 | 575,025 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 4:53 pm | N/A N/A | Definium Therapeutics Inc. | DFTX | Barrow Robert Chief Executive Officer | 320,000 | $0 | 1,098,477 (Direct) | View |
| 2026-01-29 Option Award | 2026-01-29 8:35 pm | N/A 2036-01-28 | Definium Therapeutics Inc. | DFTX | Adsett Roger Director | 50,000 | $0 | 50,000 (Direct) | View |